314 related articles for article (PubMed ID: 25366967)
1. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
2. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
Ishikawa R; Kajikawa M; Ishido S
Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
[TBL] [Abstract][Full Text] [Related]
3. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
Pennell LM; Fish EN
Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
[TBL] [Abstract][Full Text] [Related]
4. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
5. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
Periasamy P; O'Neill HC
Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
[TBL] [Abstract][Full Text] [Related]
6. CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation.
Keller CW; Kotur MB; Mundt S; Dokalis N; Ligeon LA; Shah AM; Prinz M; Becher B; Münz C; Lünemann JD
Autophagy; 2021 May; 17(5):1244-1258. PubMed ID: 32401602
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
[TBL] [Abstract][Full Text] [Related]
8. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD
PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419
[TBL] [Abstract][Full Text] [Related]
9. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.
Parker Harp CR; Archambault AS; Sim J; Ferris ST; Mikesell RJ; Koni PA; Shimoda M; Linington C; Russell JH; Wu GF
J Immunol; 2015 Jun; 194(11):5077-84. PubMed ID: 25895531
[TBL] [Abstract][Full Text] [Related]
10. The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.
Xu Y; Zhao F; Qiu Q; Chen K; Wei J; Kong Q; Gao B; Melo-Cardenas J; Zhang B; Zhang J; Song J; Zhang DD; Zhang J; Fan Y; Li H; Fang D
Nat Commun; 2016 Jul; 7():12073. PubMed ID: 27417417
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
13. MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells.
Oh J; Perry JSA; Pua H; Irgens-Möller N; Ishido S; Hsieh CS; Shin JS
J Cell Biol; 2018 Apr; 217(4):1395-1410. PubMed ID: 29371232
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4
Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD
J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505
[TBL] [Abstract][Full Text] [Related]
15. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.
Kashi VP; Ortega SB; Karandikar NJ
PLoS One; 2014; 9(8):e105763. PubMed ID: 25144738
[TBL] [Abstract][Full Text] [Related]
16. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ; Ishido S; Eisenlohr LC; Roche PA
J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
[TBL] [Abstract][Full Text] [Related]
17. Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
Lucca LE; Axisa PP; Aloulou M; Perals C; Ramadan A; Rufas P; Kyewski B; Derbinski J; Fazilleau N; Mars LT; Liblau RS
Eur J Immunol; 2016 Sep; 46(9):2247-59. PubMed ID: 27334749
[TBL] [Abstract][Full Text] [Related]
18. Altered MARCH1 ubiquination-regulated dendritic cell immune functions during the early stage of zymosan-induced multiple organ dysfunction syndrome (MODS) in mice.
Li F; Lu JY; Liu Q; Wang HW; Guo H
Immunol Lett; 2013 Feb; 150(1-2):105-15. PubMed ID: 23305794
[TBL] [Abstract][Full Text] [Related]
19. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.
Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
